Nova R Wealth Inc. Cuts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nova R Wealth Inc. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,153 shares of the medical equipment provider’s stock after selling 285 shares during the quarter. Intuitive Surgical makes up approximately 5.8% of Nova R Wealth Inc.’s holdings, making the stock its 4th largest holding. Nova R Wealth Inc.’s holdings in Intuitive Surgical were worth $11,563,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Massachusetts Financial Services Co. MA purchased a new position in shares of Intuitive Surgical during the third quarter valued at approximately $558,807,000. International Assets Investment Management LLC lifted its holdings in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock valued at $535,788,000 after purchasing an additional 1,088,415 shares during the last quarter. FMR LLC lifted its holdings in shares of Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares during the last quarter. Finally, Strategic Financial Concepts LLC lifted its holdings in shares of Intuitive Surgical by 50,740.8% during the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock valued at $163,202,000 after purchasing an additional 312,056 shares during the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $101,332.00. Following the completion of the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,720,023. This represents a 2.10 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Robert Desantis sold 376 shares of the stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the stock. Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. JPMorgan Chase & Co. boosted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Stifel Nicolaus boosted their price objective on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. CICC Research initiated coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Finally, Raymond James boosted their target price on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $591.39 on Friday. The company has a market capitalization of $210.64 billion, a P/E ratio of 92.26, a P/E/G ratio of 5.67 and a beta of 1.39. The company has a fifty day moving average of $557.70 and a 200 day moving average of $517.49. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.